ANTHARIS THERAPEUTICS
LIVE

Serial Number

99222134

Owner

Antharis Therapeutics Holdings Inc.

Attorney

Karen Won

Filing Date

Jun 6, 2025

Add to watchlist:

No watchlists yet
View on USPTO

ANTHARIS THERAPEUTICS Trademark

Serial Number: 99222134

ANTHARIS THERAPEUTICS is a trademark filed by Antharis Therapeutics Holdings Inc. on June 6, 2025. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Antharis Therapeutics Holdings Inc.

1396 Poinsettia Ave
Vista, NY 92081

Entity Type: 03

Trademark Details

Filing Date

June 6, 2025

Registration Date

Not Registered

Published for Opposition

May 12, 2026

Goods & Services

Biologics in the nature of pharmaceutical preparations for immunotherapy against cancer; Pharmaceutical and biological preparations for medical therapeutic use in oncology, immunology, and immuno-oncology; Pharmaceutical and biological preparations for preventing, diagnosing, treating and managing tumors, cancer, and inflammatory disorders; Therapeutic agents for medical use, namely, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, and engineered antibodies for increasing T-cell activation, increasing phagocytosis, reducing cytokine release, and suppressing over expressing tumors and cancer cells

Custom manufacturing of therapeutic agents, namely, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion molecular proteins, and engineered antibodies, all for use in pharmaceuticals

Research and development in the fields of immune-oncology, monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion molecular proteins, and pharmaceuticals and biologics in the field of oncology; Providing medical research information in the fields of monoclonal antibodies, antibody-drug conjugates, bispecific antibodies, fusion proteins, and pharmaceuticals and biologics in the field of oncology

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 6, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 13, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 12, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 12, 2026 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Mar 12, 2026 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Mar 4, 2026 GNFN
FINAL REFUSAL E-MAILED
Mar 4, 2026 GNFR
FINAL REFUSAL WRITTEN
Mar 4, 2026 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 3, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 3, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 3, 2026 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 3, 2025 GNRN
NON-FINAL ACTION E-MAILED
Nov 3, 2025 GNRT
NON-FINAL ACTION WRITTEN
Nov 3, 2025 CNRT
ASSIGNED TO EXAMINER
Oct 28, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 13, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 13, 2025 NWOS
NEW APPLICATION ENTERED
Jun 6, 2025 NWAP
APPLICATION FILING RECEIPT MAILED
Jun 6, 2025 MAFR